Prmt5 has been reported to be associated with the development of multiple cancers, such as lung cancer, cervical cancer, glioblastoma and liver cancer, where it boosts cancer cell hyperproliferation [24–27]. This evidence concerns the gene PRMT5 and lung carcinoma.